Characterization of the Fetal Blood Transcriptome and Proteome in Maternal Anti-Fetal Rejection: Evidence of a Distinct and Novel Type of Human Fetal Systemic Inflammatory Response

American Journal of Reproductive Immunology

Volumn 70, Issue 4, 2013, Pages 265-284

  Lee, Joonho ^a   Romero, Roberto ^a   Chaiworapongsa, Tinnakorn ^a,b   Dong, Zhong ^a   Tarca, Adi L ^a,c   Xu, Yi ^a   Chiang, Po Jen ^a   Kusanovic, Juan Pedro ^a,d,e   Hassan, Sonia S ^a,b   Yeo, Lami ^a,b   Yoon, Bo Hyun ^f   Than, Nandor Gabor ^a,b   Kim, Chong Jai ^a,g  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Wayne State University   (United States)

^d HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^e PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^f Seoul National University College of Medicine   (South Korea)

^g University of Ulsan College of Medicine   (South Korea)

Author keywords

Apolipoprotein C III; CD 34; Chronic placental inflammation; CXCL10; Pregnancy

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; HLA ANTIGEN; INTERLEUKIN 6; PANEL REACTIVE ANTIBODY; PROTEOME; TRANSCRIPTOME;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS BLOOD; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MATERNAL BLOOD; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UMBILICAL CORD BLOOD; UTERUS CONTRACTION;

APOLIPOPROTEIN C-III; CD 34; CHRONIC PLACENTAL INFLAMMATION; CXCL10; PREGNANCY;

ADOLESCENT; ADULT; CHEMOKINE CXCL10; CHORIOAMNIONITIS; FEMALE; FETAL BLOOD; FETUS; GENE EXPRESSION PROFILING; HISTOCOMPATIBILITY, MATERNAL-FETAL; HLA ANTIGENS; HUMANS; INFLAMMATION MEDIATORS; ISOANTIBODIES; PLACENTA; PREGNANCY; PREMATURE BIRTH; PROTEOME; YOUNG ADULT;

EID: 84884201693     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12142     Document Type: Article

References (171)

1. Mor G, Cardenas I: The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 2010; 63:425-433.
2. Mor G, Cardenas I, Abrahams V, Guller S: Inflammation and pregnancy: the role of the immune system at the implantation site. Ann N Y Acad Sci 2011; 1221:80-87.
3. Gotlieb WH: [Immunology of pregnancy]. Rev Med Brux 1992; 13:97-101.
4. Terness P, Kallikourdis M, Betz AG, Rabinovich GA, Saito S, Clark DA: Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells. Am J Reprod Immunol 2007; 58:238-254.
5. Blois SM, Ilarregui JM, Tometten M, Garcia M, Orsal AS, Cordo-Russo R, Toscano MA, Bianco GA, Kobelt P, Handjiski B, Tirado I, Markert UR, Klapp BF, Poirier F, Szekeres-Bartho J, Rabinovich GA, Arck PC: A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 2007; 13:1450-1457.
6. Than NG, Romero R, Erez O, Weckle A, Tarca AL, Hotra J, Abbas A, Han YM, Kim SS, Kusanovic JP, Gotsch F, Hou Z, Santolaya-Forgas J, Benirschke K, Papp Z, Grossman LI, Goodman M, Wildman DE: Emergence of hormonal and redox regulation of galectin-1 in placental mammals: implication in maternal-fetal immune tolerance. Proc Natl Acad Sci USA 2008; 105:15819-15824.
7. Than NG, Romero R, Goodman M, Weckle A, Xing J, Dong Z, Xu Y, Tarquini F, Szilagyi A, Gal P, Hou Z, Tarca AL, Kim CJ, Kim JS, Haidarian S, Uddin M, Bohn H, Benirschke K, Santolaya-Forgas J, Grossman LI, Erez O, Hassan SS, Zavodszky P, Papp Z, Wildman DE: A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death. Proc Natl Acad Sci USA 2009; 106:9731-9736.
8. Than NG, Romero R, Kim CJ, McGowen MR, Papp Z, Wildman DE: Galectins: guardians of eutherian pregnancy at the maternal-fetal interface. Trends Endocrinol Metab 2012; 23:23-31.
9. Mellor AL, Munn DH: Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses. J Reprod Immunol 2001; 52:5-13.
10. Chaouat G, Voisin GA, Daeron M, Kanellopoulos J: [Enhancing antibodies and suppressive cells in maternal anti-fetal immune reaction]. Ann Immunol (Paris) 1977; 128:21-24.
11. Trowsdale J, Betz AG: Mother's little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol 2006; 7:241-246.
12. Abrahams VM, Straszewski-Chavez SL, Guller S, Mor G: First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol Hum Reprod 2004; 10:55-63.
13. Thaxton JE, Sharma S: Interleukin-10: a multi-faceted agent of pregnancy. Am J Reprod Immunol 2010; 63:482-491.
14. Mor G: Inflammation and pregnancy: the role of toll-like receptors in trophoblast-immune interaction. Ann N Y Acad Sci 2008; 1127:121-128.
15. Wang B, Koga K, Osuga Y, Cardenas I, Izumi G, Takamura M, Hirata T, Yoshino O, Hirota Y, Harada M, Mor G, Taketani Y: Toll-like receptor-3 ligation-induced indoleamine 2, 3-dioxygenase expression in human trophoblasts. Endocrinology 2011; 152:4984-4992.
16. Kalkunte S, Chichester CO, Gotsch F, Sentman CL, Romero R, Sharma S: Evolution of non-cytotoxic uterine natural killer cells. Am J Reprod Immunol 2008; 59:425-432.
17. Than NG, Nagai A, Sharma S, Meiri H, Hauguel-de Mouzon S, Sadovsky Y, Rao ChV: Application of pregnancy-related proteins in prenatal and tumor diagnostics-a workshop report. Placenta 2005; 26(Suppl A):S110-S113.
18. Schober L, Radnai D, Schmitt E, Mahnke K, Sohn C, Steinborn A: Term and preterm labor: decreased suppressive activity and changes in composition of the regulatory T-cell pool. Immunol Cell Biol 2012; 90:935-944.
19. Steinborn A, Schmitt E, Kisielewicz A, Rechenberg S, Seissler N, Mahnke K, Schaier M, Zeier M, Sohn C: Pregnancy-associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs. Clin Exp Immunol 2012; 167:84-98.
20. Saito S, Sakai M, Sasaki Y, Nakashima A, Shiozaki A: Inadequate tolerance induction may induce pre-eclampsia. J Reprod Immunol 2007; 76:30-39.
21. Sasaki Y, Darmochwal-Kolarz D, Suzuki D, Sakai M, Ito M, Shima T, Shiozaki A, Rolinski J, Saito S: Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia. Clin Exp Immunol 2007; 149:139-145.
22. Tirado-Gonzalez I, Freitag N, Barrientos G, Shaikly V, Nagaeva O, Strand M, Kjellberg L, Klapp BF, Mincheva-Nilsson L, Cohen M, Blois SM: Galectin-1 influences trophoblast immune evasion and emerges as a predictive factor for the outcome of pregnancy. Mol Hum Reprod 2012; 19:43-53.
23. Kisielewicz A, Schaier M, Schmitt E, Hug F, Haensch GM, Meuer S, Zeier M, Sohn C, Steinborn A: A distinct subset of HLA-DR+-regulatory T cells is involved in the induction of preterm labor during pregnancy and in the induction of organ rejection after transplantation. Clin Immunol 2010; 137:209-220.
24. Steinborn A, Saran G, Schneider A, Fersis N, Sohn C, Schmitt E: The presence of gestational diabetes is associated with increased detection of anti-HLA-class II antibodies in the maternal circulation. Am J Reprod Immunol 2006; 56:124-134.
25. Steinborn A, Schmitt E, Stein Y, Klee A, Gonser M, Seifried E, Seidl C: Prolonged preterm rupture of fetal membranes, a consequence of an increased maternal anti-fetal T cell responsiveness. Pediatr Res 2005; 58:648-653.
26. Kim CJ, Romero R, Kusanovic JP, Yoo W, Dong Z, Topping V, Gotsch F, Yoon BH, Chi JG, Kim JS: The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth. Mod Pathol 2010; 23:1000-1011.
27. Lee J, Romero R, Xu Y, Kim JS, Topping V, Yoo W, Kusanovic JP, Chaiworapongsa T, Hassan SS, Yoon BH, Kim CJ: A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d. PLoS ONE 2011; 6:e16806.
28. Lee J, Romero R, Dong Z, Xu Y, Qureshi F, Jacques S, Yoo W, Chaiworapongsa T, Mittal P, Hassan SS, Kim CJ: Unexplained fetal death has a biological signature of maternal anti-fetal rejection: chronic chorioamnionitis and alloimmune anti-human leucocyte antigen antibodies. Histopathology 2011; 59:928-938.
29. Lee J, Romero R, Xu Y, Kim JS, Park JY, Kusanovic JP, Chaiworapongsa T, Hassan SS, Kim CJ: Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection. Am J Reprod Immunol 2011; 66:510-526.
30. Kim MJ, Romero R, Kim CJ, Tarca AL, Chhauy S, LaJeunesse C, Lee DC, Draghici S, Gotsch F, Kusanovic JP, Hassan SS, Kim JS: Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host disease. J Immunol 2009; 182:3919-3927.
31. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM: The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998; 179:194-202.
32. Gotsch F, Romero R, Kusanovic JP, Mazaki-Tovi S, Pineles BL, Erez O, Espinoza J, Hassan SS: The fetal inflammatory response syndrome. Clin Obstet Gynecol 2007; 50:652-683.
33. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, Berry SM: A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998; 179:186-193.
34. Goepfert AR, Andrews WW, Carlo W, Ramsey PS, Cliver SP, Goldenberg RL, Hauth JC: Umbilical cord plasma interleukin-6 concentrations in preterm infants and risk of neonatal morbidity. Am J Obstet Gynecol 2004; 191:1375-1381.
35. Chaiworapongsa T, Romero R, Kim JC, Kim YM, Blackwell SC, Yoon BH, Gomez R: Evidence for fetal involvement in the pathologic process of clinical chorioamnionitis. Am J Obstet Gynecol 2002; 186:1178-1182.
36. Romero R, Chaiworapongsa T, Espinoza J: Micronutrients and intrauterine infection, preterm birth and the fetal inflammatory response syndrome. J Nutr 2003; 133:1668S-1673S.
37. Lee SE, Romero R, Kim CJ, Shim SS, Yoon BH: Funisitis in term pregnancy is associated with microbial invasion of the amniotic cavity and intra-amniotic inflammation. J Matern Fetal Neonatal Med 2006; 19:693-697.
38. Lee SE, Romero R, Lee SM, Yoon BH: Amniotic fluid volume in intra-amniotic inflammation with and without culture-proven amniotic fluid infection in preterm premature rupture of membranes. J Perinat Med 2010; 38:39-44.
39. Gervasi MT, Romero R, Bracalente G, Chaiworapongsa T, Erez O, Dong Z, Hassan SS, Yeo L, Yoon BH, Mor G, Barzon L, Franchin E, Militello V, Palu G: Viral invasion of the amniotic cavity (VIAC) in the midtrimester of pregnancy. J Matern Fetal Neonatal Med 2012; 25:2002-2013.
40. Mittal P, Romero R, Kusanovic JP, Edwin SS, Gotsch F, Mazaki-Tovi S, Espinoza J, Erez O, Nhan-Chang CL, Than NG, Vaisbuch E, Hassan SS: CXCL6 (granulocyte chemotactic protein-2): a novel chemokine involved in the innate immune response of the amniotic cavity. Am J Reprod Immunol 2008; 60:246-257.
41. Gotsch F, Romero R, Kusanovic JP, Erez O, Espinoza J, Kim CJ, Vaisbuch E, Than NG, Mazaki-Tovi S, Chaiworapongsa T, Mazor M, Yoon BH, Edwin S, Gomez R, Mittal P, Hassan SS, Sharma S: The anti-inflammatory limb of the immune response in preterm labor, intra-amniotic infection/inflammation, and spontaneous parturition at term: a role for interleukin-10. J Matern Fetal Neonatal Med 2008; 21:529-547.
42. Romero R, Maymon E, Pacora P, Gomez R, Mazor M, Yoon BH, Berry SM: Further observations on the fetal inflammatory response syndrome: a potential homeostatic role for the soluble receptors of tumor necrosis factor alpha. Am J Obstet Gynecol 2000; 183:1070-1077.
43. Romero R, Savasan ZA, Chaiworapongsa T, Berry SM, Kusanovic JP, Hassan SS, Yoon BH, Edwin S, Mazor M: Hematologic profile of the fetus with systemic inflammatory response syndrome. J Perinat Med 2011; 40:19-32.
44. Chaiworapongsa T, Romero R, Berry SM, Hassan SS, Yoon BH, Edwin S, Mazor M: The role of granulocyte colony-stimulating factor in the neutrophilia observed in the fetal inflammatory response syndrome. J Perinat Med 2011; 39:653-666.
45. Fuksman RB, Mazzitelli NG: Second-trimester histopathological placental findings in maternal-fetal inflammatory response syndrome. Pediatr Dev Pathol 2009; 12:42-46.
46. Arad I, Ergaz Z: The fetal inflammatory response syndrome and associated infant morbidity. Isr Med Assoc J 2004; 6:766-769.
47. Erdei G, Toth P, Vasarhelyi B: [New clinical entity in perinatology: fetal inflammatory response syndrome]. Orv Hetil 2003; 144:1515-1519.
48. Pacora P, Chaiworapongsa T, Maymon E, Kim YM, Gomez R, Yoon BH, Ghezzi F, Berry SM, Qureshi F, Jacques SM, Kim JC, Kadar N, Romero R: Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med 2002; 11:18-25.
49. Park JS, Romero R, Yoon BH, Moon JB, Oh SY, Han SY, Ko EM: The relationship between amniotic fluid matrix metalloproteinase-8 and funisitis. Am J Obstet Gynecol 2001; 185:1156-1161.
50. Gravett MG, Rubens CE, Nunes TM: Global report on preterm birth and stillbirth (2 of 7): discovery science. BMC Pregnancy Childbirth 2010; 10(Suppl 1):S2.
51. Gantert M, Been JV, Gavilanes AW, Garnier Y, Zimmermann LJ, Kramer BW: Chorioamnionitis: a multiorgan disease of the fetus? J Perinatol 2010; 30(Suppl):S21-S30.
52. Sergeeva VA, Nesterenko SN, Shabalov NP, Aleksandrovich IuS: [Fetal inflammatory response in the development of multiple organ dysfunction in newborn]. Anesteziol Reanimatol 2010; 1:30-34.
53. Kim YM, Romero R, Chaiworapongsa T, Espinoza J, Mor G, Kim CJ: Dermatitis as a component of the fetal inflammatory response syndrome is associated with activation of Toll-like receptors in epidermal keratinocytes. Histopathology 2006; 49:506-514.
54. Been JV, Lievense S, Zimmermann LJ, Kramer BW, Wolfs TG: Chorioamnionitis as a risk factor for necrotizing enterocolitis: a systematic review and meta-analysis. J Pediatr 2013; 162:236-242.e2.
55. Athayde N, Wang J, Wang X, Trudinger B: Fetuses delivered following preterm prelabor rupture of the membranes are capable of stimulating a proinflammatory response in endothelial cells. J Soc Gynecol Investig 2005; 12:118-122.
56. Morais Pereira LH, Pacheco Olegario JG, Rocha LP, de Oliveira Guimaraes CS, Ramalho FS, Dos Reis MA, Miranda Correa RR: Association Between the Markers of FIRS and the Morphologic Alterations in the Liver of Neonates Autopsied in the Perinatal Period. Fetal Pediatr Pathol 2013; 31:48-54.
57. Sood BG, Madan A, Saha S, Schendel D, Thorsen P, Skogstrand K, Hougaard D, Shankaran S, Carlo W: Perinatal systemic inflammatory response syndrome and retinopathy of prematurity. Pediatr Res 2010; 67:394-400.
58. Romero R, Soto E, Berry SM, Hassan SS, Kusanovic JP, Yoon BH, Edwin S, Mazor M, Chaiworapongsa T: Blood pH and gases in fetuses in preterm labor with and without systemic inflammatory response syndrome. J Matern Fetal Neonatal Med 2012; 25:1160-1170.
59. Pereira L, Reddy AP, Alexander AL, Lu X, Lapidus JA, Gravett MG, Nagalla SR: Insights into the multifactorial nature of preterm birth: proteomic profiling of the maternal serum glycoproteome and maternal serum peptidome among women in preterm labor. Am J Obstet Gynecol 2010; 202:555.e1-555.e10.
60. De Felice C, Bagnoli F, Toti P, Musaro MA, Peruzzi L, Paffetti P, Latini G: Transient hypothyroxinemia of prematurity and histological chorioamnionitis. J Perinat Med 2005; 33:514-518.
61. Lucovnik M, Kornhauser-Cerar L, Premru-Srsen T, Gmeiner-Stopar T, Derganc M: Neutrophil defensins but not interleukin-6 in vaginal fluid after preterm premature rupture of membranes predict fetal/neonatal inflammation and infant neurological impairment. Acta Obstet Gynecol Scand 2011; 90:908-916.
62. Kim SK, Romero R, Chaiworapongsa T, Kusanovic JP, Mazaki-Tovi S, Mittal P, Erez O, Vaisbuch E, Gotsch F, Pacora P, Yeo L, Gervasi MT, Lamont RF, Yoon BH, Hassan SS: Evidence of changes in the immunophenotype and metabolic characteristics (intracellular reactive oxygen radicals) of fetal, but not maternal, monocytes and granulocytes in the fetal inflammatory response syndrome. J Perinat Med 2009; 37:543-552.
63. El-Haieg DO, Zidan AA, El-Nemr MM: The relationship between sonographic fetal thymus size and the components of the systemic fetal inflammatory response syndrome in women with preterm prelabour rupture of membranes. BJOG 2008; 115:836-841.
64. Di Naro E, Cromi A, Ghezzi F, Raio L, Uccella S, D'Addario V, Loverro G: Fetal thymic involution: a sonographic marker of the fetal inflammatory response syndrome. Am J Obstet Gynecol 2006; 194:153-159.
65. Toti P, De Felice C, Stumpo M, Schurfeld K, Di Leo L, Vatti R, Bianciardi G, Buonocore G, Seemayer TA, Luzi P: Acute thymic involution in fetuses and neonates with chorioamnionitis. Hum Pathol 2000; 31:1121-1128.
66. Wolfs TG, Jellema RK, Turrisi G, Becucci E, Buonocore G, Kramer BW: Inflammation-induced immune suppression of the fetus: a potential link between chorioamnionitis and postnatal early onset sepsis. J Matern Fetal Neonatal Med 2012; 25(Suppl 1):8-11.
67. Speer CP: Neonatal respiratory distress syndrome: an inflammatory disease? Neonatology 2011; 99:316-319.
68. Lee J, Oh KJ, Park CW, Park JS, Jun JK, Yoon BH: The presence of funisitis is associated with a decreased risk for the development of neonatal respiratory distress syndrome. Placenta 2011; 32:235-240.
69. Lahra MM, Beeby PJ, Jeffery HE: Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13-year hospital cohort study. Pediatrics 2009; 123:1314-1319.
70. Kramer BW: Antenatal inflammation and lung injury: prenatal origin of neonatal disease. J Perinatol 2008; 28(Suppl 1):S21-S27.
71. Mittendorf R, Covert R, Montag AG, elMasri W, Muraskas J, Lee KS, Pryde PG: Special relationships between fetal inflammatory response syndrome and bronchopulmonary dysplasia in neonates. J Perinat Med 2005; 33:428-434.
72. Sweet DG, Halliday HL: Modeling and remodeling of the lung in neonatal chronic lung disease: implications for therapy. Treat Respir Med 2005; 4:347-359.
73. Blanco-Quiros A, Arranz E, Solis G, Garrote JA, Mayo A: High cord blood IL-10 levels in preterm newborns with respiratory distress syndrome. Allergol Immunopathol (Madr) 2004; 32:189-196.
74. Hallman M: Cytokines, pulmonary surfactant and consequences of intrauterine infection. Biol Neonate 1999; 76(Suppl 1):2-9.
75. Nishimaki S, Sato M, An H, Shima Y, Akaike T, Yokoyama U, Yokota S: Comparison of markers for fetal inflammatory response syndrome: fetal blood interleukin-6 and neonatal urinary beta(2)-microglobulin. J Obstet Gynaecol Res 2009; 35:472-476.
76. Letti Muller AL, Barrios Pde M, Kliemann LM, Valerio EG, Gasnier R, Magalhaes JA: Tei index to assess fetal cardiac performance in fetuses at risk for fetal inflammatory response syndrome. Ultrasound Obstet Gynecol 2010; 36:26-31.
77. Romero R, Espinoza J, Goncalves LF, Gomez R, Medina L, Silva M, Chaiworapongsa T, Yoon BH, Ghezzi F, Lee W, Treadwell M, Berry SM, Maymon E, Mazor M, DeVore G: Fetal cardiac dysfunction in preterm premature rupture of membranes. J Matern Fetal Neonatal Med 2004; 16:146-157.
78. Kuypers E, Ophelders D, Jellema RK, Kunzmann S, Gavilanes AW, Kramer BW: White matter injury following fetal inflammatory response syndrome induced by chorioamnionitis and fetal sepsis: lessons from experimental ovine models. Early Hum Dev 2012; 88:931-936.
79. Resch B, Radinger A, Mannhalter C, Binder A, Haas J, Muller WD: Interleukin-6 G(-174)C polymorphism is associated with mental retardation in cystic periventricular leucomalacia in preterm infants. Arch Dis Child Fetal Neonatal Ed 2009; 94:F304-F306.
80. Bashiri A, Burstein E, Mazor M: Cerebral palsy and fetal inflammatory response syndrome: a review. J Perinat Med 2006; 34:5-12.
81. Mittendorf R, Montag AG, MacMillan W, Janeczek S, Pryde PG, Besinger RE, Gianopoulos JG, Roizen N: Components of the systemic fetal inflammatory response syndrome as predictors of impaired neurologic outcomes in children. Am J Obstet Gynecol 2003; 188:1438-1444; discussion 1444-1446.
82. Svigos JM: The fetal inflammatory response syndrome and cerebral palsy: yet another challenge and dilemma for the obstetrician. Aust N Z J Obstet Gynaecol 2001; 41:170-176.
83. Lautridou A, Ancel PY, Launay E, Denizot S, Orsonneau JL, Roze JC, Gras-Le Guen C: Umbilical cord blood procalcitonin as a risk factor for mortality in very premature infants. Eur J Clin Microbiol Infect Dis 2012; 31:2407-2412.
84. Madsen-Bouterse SA, Romero R, Tarca AL, Kusanovic JP, Espinoza J, Kim CJ, Kim JS, Edwin SS, Gomez R, Draghici S: The transcriptome of the fetal inflammatory response syndrome. Am J Reprod Immunol 2010; 63:73-92.
85. Kanamori Y, Terawaki K, Takayasu H, Sugiyama M, Komura M, Kodaka T, Suzuki K, Kitano Y, Kuroda T, Iwanaka T: Interleukin 6 and interleukin 8 play important roles in systemic inflammatory response syndrome of meconium peritonitis. Surg Today 2012; 42:431-434.
86. Savasan ZA, Chaiworapongsa T, Romero R, Hussein Y, Kusanovic JP, Xu Y, Dong Z, Kim CJ, Hassan SS: Interleukin-19 in fetal systemic inflammation. J Matern Fetal Neonatal Med 2012; 25:995-1005.
87. Ozdemir O, Dinleyici EC, Tekin N, Colak O, Aksit MA: Low-mannose-binding lectin levels in susceptibility to neonatal sepsis in preterm neonates with fetal inflammatory response syndrome. J Matern Fetal Neonatal Med 2010; 23:1009-1013.
88. Salvesen B, Fung M, Saugstad OD, Mollnes TE: Role of complement and CD14 in meconium-induced cytokine formation. Pediatrics 2008; 121:e496-e505.
89. Yoon BH, Romero R, Park JS, Kim M, Oh SY, Kim CJ, Jun JK: The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol 2000; 183:1124-1129.
90. Sadowsky DW, Adams KM, Gravett MG, Witkin SS, Novy MJ: Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am J Obstet Gynecol 2006; 195:1578-1589.
91. Collins JJ, Kallapur SG, Knox CL, Nitsos I, Polglase GR, Pillow JJ, Kuypers E, Newnham JP, Jobe AH, Kramer BW: Inflammation in fetal sheep from intra-amniotic injection of Ureaplasma parvum. Am J Physiol Lung Cell Mol Physiol 2010; 299:L852-L860.
92. Gantert M, Jellema RK, Heineman H, Gantert J, Collins JJ, Seehase M, Lambermont VA, Keck A, Garnier Y, Zimmermann LJ, Kadyrov M, Gavilanes AW, Kramer BW: Lipopolysaccharide-induced chorioamnionitis is confined to one amniotic compartment in twin pregnant sheep. Neonatology 2012; 102:81-88.
93. Debillon T, Gras-Leguen C, Leroy S, Caillon J, Roze JC, Gressens P: Patterns of cerebral inflammatory response in a rabbit model of intrauterine infection-mediated brain lesion. Brain Res Dev Brain Res 2003; 145:39-48.
94. Harju K, Ojaniemi M, Rounioja S, Glumoff V, Paananen R, Vuolteenaho R, Hallman M: Expression of toll-like receptor 4 and endotoxin responsiveness in mice during perinatal period. Pediatr Res 2005; 57:644-648.
95. Kallapur SG, Kramer BW, Nitsos I, Pillow JJ, Collins JJ, Polglase GR, Newnham JP, Jobe AH: Pulmonary and systemic inflammatory responses to intra-amniotic IL-1alpha in fetal sheep. Am J Physiol Lung Cell Mol Physiol 2011; 301:L285-L295.
96. Boles JL, Ross MG, Beloosesky R, Desai M, Belkacemi L: Placental-mediated increased cytokine response to lipopolysaccharides: a potential mechanism for enhanced inflammation susceptibility of the preterm fetus. J Inflamm Res 2012; 5:67-75.
97. Waldorf KM, Gravett MG, McAdams RM, Paolella LJ, Gough GM, Carl DJ, Bansal A, Liggitt HD, Kapur RP, Reitz FB, Rubens CE: Choriodecidual group B streptococcal inoculation induces fetal lung injury without intra-amniotic infection and preterm labor in Macaca nemestrina. PLoS ONE 2011; 6:e28972.
98. Seehase M, Gantert M, Ladenburger A, Garnier Y, Kunzmann S, Thomas W, Wirbelauer J, Speer CP, Kramer BW: Myocardial response in preterm fetal sheep exposed to systemic endotoxinaemia. Pediatr Res 2011; 70:242-246.
99. Bieghs V, Vlassaks E, Custers A, van Gorp PJ, Gijbels MJ, Bast A, Bekers O, Zimmermann LJ, Lutjohann D, Voncken JW, Gavilanes AW, Kramer BW, Shiri-Sverdlov R: Chorioamnionitis induced hepatic inflammation and disturbed lipid metabolism in fetal sheep. Pediatr Res 2010; 68:466-472.
100. Grigsby PL, Novy MJ, Adams Waldorf KM, Sadowsky DW, Gravett MG: Choriodecidual inflammation: a harbinger of the preterm labor syndrome. Reprod Sci 2010; 17:85-94.
101. Kallapur SG, Nitsos I, Moss TJ, Polglase GR, Pillow JJ, Cheah FC, Kramer BW, Newnham JP, Ikegami M, Jobe AH: IL-1 mediates pulmonary and systemic inflammatory responses to chorioamnionitis induced by lipopolysaccharide. Am J Respir Crit Care Med 2009; 179:955-961.
102. Kannan S, Saadani-Makki F, Muzik O, Chakraborty P, Mangner TJ, Janisse J, Romero R, Chugani DC: Microglial activation in perinatal rabbit brain induced by intrauterine inflammation: detection with 11C-(R)-PK11195 and small-animal PET. J Nucl Med 2007; 48:946-954.
103. Garnier Y, Coumans AB, Berger R, Hasaart TH: Pulmonary perfusion during lipopolysaccharide (LPS) induced fetal endotoxemia in the preterm fetal sheep. Eur J Obstet Gynecol Reprod Biol 2006; 124:150-157.
104. Rounioja S, Rasanen J, Glumoff V, Ojaniemi M, Makikallio K, Hallman M: Intra-amniotic lipopolysaccharide leads to fetal cardiac dysfunction. A mouse model for fetal inflammatory response. Cardiovasc Res 2003; 60:156-164.
105. Burd I, Balakrishnan B, Kannan S: Models of fetal brain injury, intrauterine inflammation, and preterm birth. Am J Reprod Immunol 2012; 67:287-294.
106. Yang Q, El-Sayed Y, Rosenberg-Hasson Y, Hirschberg DL, Nayak NR, Schilling J, Madan A: Multiple cytokine profile in plasma and amniotic fluid in a mouse model of pre-term labor. Am J Reprod Immunol 2009; 62:339-347.
107. Koga K, Cardenas I, Aldo P, Abrahams VM, Peng B, Fill S, Romero R, Mor G: Activation of TLR3 in the trophoblast is associated with preterm delivery. Am J Reprod Immunol 2009; 61:196-212.
108. Cardenas I, Mor G, Aldo P, Lang SM, Stabach P, Sharp A, Romero R, Mazaki-Tovi S, Gervasi M, Means RE: Placental viral infection sensitizes to endotoxin-induced pre-term labor: a double hit hypothesis. Am J Reprod Immunol 2011; 65:110-117.
109. Thaxton JE, Romero R, Sharma S: TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes. J Immunol 2009; 183:1144-1154.
110. Murphy SP, Hanna NN, Fast LD, Shaw SK, Berg G, Padbury JF, Romero R, Sharma S: Evidence for participation of uterine natural killer cells in the mechanisms responsible for spontaneous preterm labor and delivery. Am J Obstet Gynecol 2009; 200:308.e1-308.e9.
111. Wolfs TG, Kallapur SG, Knox CL, Thuijls G, Nitsos I, Polglase GR, Collins JJ, Kroon E, Spierings J, Shroyer NF, Newnham JP, Jobe AH, Kramer BW: Antenatal ureaplasma infection impairs development of the fetal ovine gut in an IL-1-dependent manner. Mucosal Immunol 2013; 6:547-556.
112. Gantert M, Kreczmanski P, Kuypers E, Jellema R, Strackx E, Bastian N, Gavilanes AW, Zimmermann LJ, Garnier Y, Schmitz C, Kramer BW: Effects of in utero endotoxemia on the ovine fetal brain: a model for schizophrenia? Front Biosci (Elite Ed) 2012; 4:2845-2853.
113. Zhang L, Saito M, Jobe A, Kallapur SG, Newnham JP, Cox T, Kramer B, Yang H, Kemp MW: Intra-amniotic administration of E. coli lipopolysaccharides causes sustained inflammation of the fetal skin in sheep. Reprod Sci 2012; 19:1181-1189.
114. Kemp MW, Saito M, Kallapur SG, Jobe AH, Keelan JA, Li S, Kramer B, Zhang L, Knox C, Yaegashi N, Newnham JP: Inflammation of the fetal ovine skin following in utero exposure to Ureaplasma parvum. Reprod Sci 2011; 18:1128-1137.
115. Kramer BW: Chorioamnionitis - new ideas from experimental models. Neonatology 2011; 99:320-325.
116. Gravett MG, Adams KM, Sadowsky DW, Grosvenor AR, Witkin SS, Axthelm MK, Novy MJ: Immunomodulators plus antibiotics delay preterm delivery after experimental intraamniotic infection in a nonhuman primate model. Am J Obstet Gynecol 2007; 197:518.e1-518.e8.
117. Sadowsky DW, Novy MJ, Witkin SS, Gravett MG: Dexamethasone or interleukin-10 blocks interleukin-1beta-induced uterine contractions in pregnant rhesus monkeys. Am J Obstet Gynecol 2003; 188:252-263.
118. Gross G, Imamura T, Vogt SK, Wozniak DF, Nelson DM, Sadovsky Y, Muglia LJ: Inhibition of cyclooxygenase-2 prevents inflammation-mediated preterm labor in the mouse. Am J Physiol Regul Integr Comp Physiol 2000; 278:R1415-R1423.
119. Gervasi MT, Romero R, Bracalente G, Erez O, Dong Z, Hassan SS, Yeo L, Yoon BH, Chaiworapongsa T: Midtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-amniotic inflammation and associations with spontaneous early (<32 weeks) and late (>32 weeks) preterm delivery. J Perinat Med 2012; 40:329-343.
120. Yoon BH, Romero R, Moon JB, Shim SS, Kim M, Kim G, Jun JK: Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2001; 185:1130-1136.
121. Yoon BH, Romero R, Kim CJ, Jun JK, Gomez R, Choi JH, Syn HC: Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol 1995; 172:960-970.
122. Romero R, Yoon BH, Mazor M, Gomez R, Gonzalez R, Diamond MP, Baumann P, Araneda H, Kenney JS, Cotton DB, Sehgal P: A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, interleukin-6, and gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 1993; 169:839-851.
123. Romero R, Yoon BH, Mazor M, Gomez R, Diamond MP, Kenney JS, Ramirez M, Fidel PL, Sorokin Y, Cotton D, Sehgal P: The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and gram stain in patients with preterm labor and intact membranes. Am J Obstet Gynecol 1993; 169:805-816.
124. Romero R, Yoon BH, Kenney JS, Gomez R, Allison AC, Sehgal PB: Amniotic fluid interleukin-6 determinations are of diagnostic and prognostic value in preterm labor. Am J Reprod Immunol 1993; 30:167-183.
125. Romero R, Sepulveda W, Kenney JS, Archer LE, Allison AC, Sehgal PB: Interleukin 6 determination in the detection of microbial invasion of the amniotic cavity. Ciba Found Symp 1992; 167:205-220; discussion 220-203.
126. Yoon BH, Kim YA, Romero R, Kim JC, Park KH, Kim MH, Park JS: Association of oligohydramnios in women with preterm premature rupture of membranes with an inflammatory response in fetal, amniotic, and maternal compartments. Am J Obstet Gynecol 1999; 181:784-788.
127. Ogge G, Romero R, Lee DC, Gotsch F, Than NG, Lee J, Chaiworapongsa T, Dong Z, Mittal P, Hassan SS, Kim CJ: Chronic chorioamnionitis displays distinct alterations of the amniotic fluid proteome. J Pathol 2011; 223:553-565.
128. Redline RW, Heller D, Keating S, Kingdom J: Placental diagnostic criteria and clinical correlation-a workshop report. Placenta 2005; 26(Suppl A):S114-S117.
129. Kim JS, Romero R, Kim MR, Kim YM, Friel L, Espinoza J, Kim CJ: Involvement of Hofbauer cells and maternal T cells in villitis of unknown aetiology. Histopathology 2008; 52:457-464.
130. Gersell DJ, Phillips NJ, Beckerman K: Chronic chorioamnionitis: a clinicopathologic study of 17 cases. Int J Gynecol Pathol 1991; 10:217-229.
131. Jacques SM, Qureshi F: Chronic chorioamnionitis: a clinicopathologic and immunohistochemical study. Hum Pathol 1998; 29:1457-1461.
132. Khong TY, Bendon RW, Qureshi F, Redline RW, Gould S, Stallmach T, Lipsett J, Staples A: Chronic deciduitis in the placental basal plate: definition and interobserver reliability. Hum Pathol 2000; 31:292-295.
133. Bartel G, Wahrmann M, Exner M, Regele H, Schillinger M, Horl WH, Bohmig GA: Determinants of the complement-fixing ability of recipient presensitization against HLA antigens. Transplantation 2007; 83:727-733.
134. Betkowski AS, Graff R, Chen JJ, Hauptman PJ: Panel-reactive antibody screening practices prior to heart transplantation. J Heart Lung Transplant 2002; 21:644-650.
135. Bolstad BM, Irizarry RA, Astrand M, Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19:185-193.
136. Smyth GK, Yang YH, Speed T: Statistical issues in cDNA microarray data analysis. Methods Mol Biol 2003; 224:111-136.
137. Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC, Collins PJ, de Longueville F, Kawasaki ES, Lee KY, Luo Y, Sun YA, Willey JC, Setterquist RA, Fischer GM, Tong W, Dragan YP, Dix DJ, Frueh FW, Goodsaid FM, Herman D, Jensen RV, Johnson CD, Lobenhofer EK, Puri RK, Schrf U, Thierry-Mieg J, Wang C, Wilson M, Wolber PK, Zhang L, Amur S, Bao W, Barbacioru CC, Lucas AB, Bertholet V, Boysen C, Bromley B, Brown D, Brunner A, Canales R, Cao XM, Cebula TA, Chen JJ, Cheng J, Chu TM, Chudin E, Corson J, Corton JC, Croner LJ, Davies C, Davison TS, Delenstarr G, Deng X, Dorris D, Eklund AC, Fan XH, Fang H, Fulmer-Smentek S, Fuscoe JC, Gallagher K, Ge W, Guo L, Guo X, Hager J, Haje PK, Han J, Han T, Harbottle HC, Harris SC, Hatchwell E, Hauser CA, Hester S, Hong H, Hurban P, Jackson SA, Ji H, Knight CR, Kuo WP, LeClerc JE, Levy S, Li QZ, Liu C, Liu Y, Lombardi MJ, Ma Y, Magnuson SR, Maqsodi B, McDaniel T, Mei N, Myklebost O, Ning B, Novoradovskaya N, Orr MS, Osborn TW, Papallo A, Patterson TA, Perkins RG, Peters EH, Peterson R, Philips KL, Pine PS, Pusztai L, Qian F, Ren H, Rosen M, Rosenzweig BA, Samaha RR, Schena M, Schroth GP, Shchegrova S, Smith DD, Staedtler F, Su Z, Sun H, Szallasi Z, Tezak Z, Thierry-Mieg D, Thompson KL, Tikhonova I, Turpaz Y, Vallanat B, Van C, Walker SJ, Wang SJ, Wang Y, Wolfinger R, Wong A, Wu J, Xiao C, Xie Q, Xu J, Yang W, Zhong S, Zong Y, Slikker Jr W: The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 2006; 24:1151-1161.
138. Khatri P, Draghici S, Ostermeier GC, Krawetz SA: Profiling gene expression using onto-express. Genomics 2002; 79:266-270.
139. Falcon S, Gentleman R: Using GOstats to test gene lists for GO term association. Bioinformatics 2007; 23:257-258.
140. Baid S, Saidman SL, Tolkoff-Rubin N, Williams WW, Delmonico FL, Cosimi AB, Pascual M: Managing the highly sensitized transplant recipient and B cell tolerance. Curr Opin Immunol 2001; 13:577-581.
141. Zeevi A, Girnita A, Duquesnoy R: HLA antibody analysis: sensitivity, specificity, and clinical significance in solid organ transplantation. Immunol Res 2006; 36:255-264.
142. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B: Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996; 184:963-969.
143. Taub DD, Lloyd AR, Conlon K, Wang JM, Ortaldo JR, Harada A, Matsushima K, Kelvin DJ, Oppenheim JJ: Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 1993; 177:1809-1814.
144. Taub DD, Sayers TJ, Carter CR, Ortaldo JR: Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol 1995; 155:3877-3888.
145. Campbell JD, Gangur V, Simons FE, HayGlass KT: Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop. FASEB J 2004; 18:329-331.
146. Romagnani P, Crescioli C: CXCL10: a candidate biomarker in transplantation. Clin Chim Acta 2012; 413:1364-1373.
147. Tan J, Zhou G: Chemokine receptors and transplantation. Cell Mol Immunol 2005; 2:343-349.
148. Wysocki CA, Panoskaltsis-Mortari A, Blazar BR, Serody JS: Leukocyte migration and graft-versus-host disease. Blood 2005; 105:4191-4199.
149. Agostini C, Calabrese F, Rea F, Facco M, Tosoni A, Loy M, Binotto G, Valente M, Trentin L, Semenzato G: Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol 2001; 158:1703-1711.
150. Belperio JA, Keane MP, Burdick MD, Lynch III JP, Xue YY, Li K, Ross DJ, Strieter RM: Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol 2002; 169:1037-1049.
151. Crescioli C, Buonamano A, Scolletta S, Sottili M, Francalanci M, Giomarelli P, Biagioli B, Lisi G, Pradella F, Serio M, Romagnani P, Maccherini M: Predictive role of pretransplant serum CXCL10 for cardiac acute rejection. Transplantation 2009; 87:249-255.
152. Fahmy NM, Yamani MH, Starling RC, Ratliff NB, Young JB, McCarthy PM, Feng J, Novick AC, Fairchild RL: Chemokine and receptor-gene expression during early and late acute rejection episodes in human cardiac allografts. Transplantation 2003; 75:2044-2047.
153. Hoffman SA, Wang L, Shah CV, Ahya VN, Pochettino A, Olthoff K, Shaked A, Wille K, Lama VN, Milstone A, Ware LB, Orens J, Weinacker A, Demissie E, Bellamy S, Kawut SM, Hancock WW, Christie JD: Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am J Transplant 2009; 9:389-396.
154. Lazzeri E, Rotondi M, Mazzinghi B, Lasagni L, Buonamano A, Rosati A, Pradella F, Fossombroni V, La Villa G, Gacci M, Bertoni E, Serio M, Salvadori M, Romagnani P: High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy. Transplantation 2005; 79:1215-1220.
155. Lo DJ, Weaver TA, Kleiner DE, Mannon RB, Jacobson LM, Becker BN, Swanson SJ, Hale DA, Kirk AD: Chemokines and their receptors in human renal allotransplantation. Transplantation 2011; 91:70-77.
156. Melter M, Exeni A, Reinders ME, Fang JC, McMahon G, Ganz P, Hancock WW, Briscoe DM: Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation 2001; 104:2558-2564.
157. Segerer S, Cui Y, Eitner F, Goodpaster T, Hudkins KL, Mack M, Cartron JP, Colin Y, Schlondorff D, Alpers CE: Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis 2001; 37:518-531.
158. Rotondi M, Rosati A, Buonamano A, Lasagni L, Lazzeri E, Pradella F, Fossombroni V, Cirami C, Liotta F, La Villa G, Serio M, Bertoni E, Salvadori M, Romagnani P: High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure. Am J Transplant 2004; 4:1466-1474.
159. Tanner SM, Austin JL, Leone G, Rush LJ, Plass C, Heinonen K, Mrozek K, Sill H, Knuutila S, Kolitz JE, Archer KJ, Caligiuri MA, Bloomfield CD, de La Chapelle A: BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia. Proc Natl Acad Sci USA 2001; 98:13901-13906.
160. Qian Z, Fernald AA, Godley LA, Larson RA, Le Beau MM: Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia. Proc Natl Acad Sci USA 2002; 99:14925-14930.
161. Gramatges MM, Fani P, Nadeau K, Pereira S, Jeng MR: Neonatal alloimmune thrombocytopenia and neutropenia associated with maternal human leukocyte antigen antibodies. Pediatr Blood Cancer 2009; 53:97-99.
162. Tomicic M, Starcevic M, Bux J, Zach V, Hundric-Haspl Z, Drazic V, Grahovac B: Severe neonatal neutropenia due to anti-human leucocyte antigen B49 alloimmunization only: a case report. Transfus Med 2003; 13:233-237.
163. Chan DC, Chen MM, Ooi EM, Watts GF: An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor? Int J Clin Pract 2008; 62:799-809.
164. Kawakami A, Yoshida M: Apolipoprotein CIII links dyslipidemia with atherosclerosis. J Atheroscler Thromb 2009; 16:6-11.
165. Godfrey KM, Barker DJ: Fetal programming and adult health. Public Health Nutr 2001; 4:611-624.
166. Ravelli GP, Stein ZA, Susser MW: Obesity in young men after famine exposure in utero and early infancy. N Engl J Med 1976; 295:349-353.
167. Stein AD, Zybert PA, van der Pal-de Bruin K, Lumey LH: Exposure to famine during gestation, size at birth, and blood pressure at age 59 y: evidence from the Dutch Famine. Eur J Epidemiol 2006; 21:759-765.
168. Roseboom TJ, van der Meulen JH, Osmond C, Barker DJ, Ravelli AC, Schroeder-Tanka JM, van Montfrans GA, Michels RP, Bleker OP: Coronary heart disease after prenatal exposure to the Dutch famine, 1944-45. Heart 2000; 84:595-598.
169. Lussana F, Painter RC, Ocke MC, Buller HR, Bossuyt PM, Roseboom TJ: Prenatal exposure to the Dutch famine is associated with a preference for fatty foods and a more atherogenic lipid profile. Am J Clin Nutr 2008; 88:1648-1652.
170. Colvin RB, Smith RN: Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005; 5:807-817.
171. Le Moine A, Goldman M, Abramowicz D: Multiple pathways to allograft rejection. Transplantation 2002; 73:1373-1381.